Medifast Inc (MED)

EBITDA Growth

-93.42%

Quarterly · Period ending:

MED logo

MED EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-93.42%
MED Quarterly EBITDA YoY % (-218.18% → -93.42%)
High-resolution chart · PNG

MED ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Medifast Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-93.4249%
-59.485%
-165.4036%
-83.3403%
191.2568%
-74.3635%
-66.0965%
-84.0726%
-117.8487%
-73.7165%
-63.0374%
-41.2403%
-17.8113%
-1.7926%
-30.826%
-9.9134%
-17.6105%
6.6614%
28.6926%
22.1486%
109.6888%
114.0481%
100.2153%
109.9452%
3.0373%
-4.2821%
-3.6247%
20.6263%
59.0742%
62.1926%
97.4931%
61.7057%
47.8138%
67.5478%
34.3622%
11.2805%
92.6377%
22.9529%
8.0842%
4.6629%
-38.7738%
-6.1032%
-19.0044%
14.3076%
-12.0084%
-27.9296%
-14.9924%
-15.3486%
-10.0665%
3.8544%
59.3318%
-16.0324%
78.6418%
31.5802%
42.4092%
35.2449%
-33.0955%
-27.5126%
-32.5259%
-16.0797%
3.7096%
22.419%
5.7888%
53.5938%
75.1436%
83.0124%
160.3698%
92.1289%
70.4895%
66.985%
43.4006%
46.4315%
49.0826%
6.8004%
108.3425%
4.4559%
-9.8835%
-23.5309%
-1,994.0801%
33.8303%
67.2533%
178.2923%
12.5%
94.6429%
30.4098%
13.0933%
22.9219%
4.5508%
13.0677%
-20.9061%
432.8859%
1.7815%
48.2143%
336.4407%
13.7405%
343.1579%
143.4783%
-21.1581%
-58.4069%
58.1462%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.